BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36693491)

  • 21. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
    Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY
    World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown.
    Gao Y; Gong Y; Liu Y; Xue Y; Zheng K; Guo Y; Hao L; Peng Q; Shi X
    Acta Histochem; 2023 Jan; 125(1):151987. PubMed ID: 36473310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
    Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
    Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
    Wang J; Zhang X; Ma X; Chen D; Cai M; Xiao L; Li J; Huang Z; Huang Y; Lian Y
    J Exp Clin Cancer Res; 2023 Nov; 42(1):303. PubMed ID: 37968706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1.
    Liu YP; Pan LL; Kong CC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y; Cao K
    J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression.
    Lv T; Xiong X; Yan W; Liu M; Xu H; He Q
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR‑375 sponging.
    Zhao L; Lou G; Li A; Liu Y
    Mol Med Rep; 2020 Aug; 22(2):1449-1457. PubMed ID: 32626943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma.
    Guo Y; Peng Q; Hao L; Ji J; Zhang Z; Xue Y; Liu Y; Gao Y; Li C; Shi X
    FASEB J; 2022 Jun; 36(6):e22361. PubMed ID: 35616366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of RBM3 in the regulation of cell proliferation in hepatocellular carcinoma.
    Miao X; Zhang N
    Exp Mol Pathol; 2020 Dec; 117():104546. PubMed ID: 32976820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
    Behnke MK; Reimers M; Fisher RA
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.
    Xu B; Li SH; Zheng R; Gao SB; Ding LH; Yin ZY; Lin X; Feng ZJ; Zhang S; Wang XM; Jin GH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17480-5. PubMed ID: 24101467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability.
    Che N; Ng KY; Wong TL; Tong M; Kau PW; Chan LH; Lee TK; Huen MS; Yun JP; Ma S
    Cancer Lett; 2021 Mar; 501():247-262. PubMed ID: 33186656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.